First Cancer Immunotherapy Regimen Approved for Breast Cancer
March 9th 2019Atezolizumab (Tecentriq) plus chemotherapy is approved under the FDA’s Accelerated Approval Program, which allows conditional approval of a medicine that fills an unmet medical need for a serious or life-threatening disease or condition.
Read More
Study: 2 Strains of HPV Decrease Due to HPV Vaccination
March 3rd 2019Investigators from the CDC Human Papillomavirus (HPV) Vaccine Impact Monitoring Project (HPV-IMPACT) sought to determine whether HPV types 16 and 18, which are responsible for approximately 70% of cervical cancers worldwide, are also decreasing.
Read More